跳至主要内容
临床试验/JPRN-UMIN000012617
JPRN-UMIN000012617已完成未知

A study about the impact of intensive instruction on the use of Aricept and the reasons for discontinuation in patients with Alzheimer's Disease - A study about the impact of intensive instruction on the use of Aricept and the reasons for discontinuation in patients with Alzheimer's Disease

Shonan Fujisawa Tokushukai Hospital0 个研究点目标入组 150 人开始时间: 2013年12月18日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • •1) Patients treated with donepezil, galantamine, rivastigmine in 4 weeks immediately before enrollment 2) Known hypersensitivity to donepezil or piperadine derivatives 3) Involvement in any other investigational drug clinical trial during the preceding 12 weeks

研究者

相似试验